Journal Article

Eligibility for Treatment of Hepatitis C Virus Infection among Young Injection Drug Users in 3 US Cities

Holly Hagan, Mary H. Latka, Jennifer V. Campbell, Elizabeth T. Golub, Richard S. Garfein, David A. Thomas, Farzana Kapadia and Steffanie A. Strathdee

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 42, issue 5, pages 669-672
Published in print March 2006 | ISSN: 1058-4838
Published online March 2006 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/499951
Eligibility for Treatment of Hepatitis C Virus Infection among Young Injection Drug Users in 3 US Cities

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Among 404 injection drug users aged 18–35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

Journal Article.  2595 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.